MarketCap
Facebook
X
TelegramCleveland BioLabs, Inc. DSO 2011-2026 | CBLI
DSO Jährlich Cleveland BioLabs, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 16 | 124 | 80.8 | 104 | 36.6 | 85.1 | 26.3 | 19.7 | 4.28 | 72.3 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 124 | 4.28 | 56.9 |
DSO anderer Aktien in der Pharmaeinzelhändler
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
169 | $ 9.13 | -0.76 % | $ 591 M |  USA |
 |
I-Mab
IMAB
|
271 | - | - | $ 866 M |  China |
 |
Midatech Pharma plc
MTP
|
204 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 | - | - | $ 40.3 B | USA |
 |
Aptorum Group Limited
APM
|
20.6 | $ 0.91 | 2.42 % | $ 6.69 M | China |
 |
Edesa Biotech
EDSA
|
97.1 | $ 15.52 | -2.39 % | $ 49.6 M | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
37.5 | $ 22.47 | 1.19 % | $ 3.72 B | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K | - | -1.52 % | $ 24.7 M | USA |
 |
Fortress Biotech
FBIO
|
115 | $ 2.24 | 0.9 % | $ 62.5 M | USA |
 |
Galapagos NV
GLPG
|
56.5 | $ 28.07 | 0.75 % | $ 2.69 B |  Belgium |
 |
Advaxis
ADXS
|
88.1 | - | -9.65 % | $ 45.9 M | USA |
 |
Harmony Biosciences Holdings
HRMY
|
37.8 | $ 31.01 | -0.13 % | $ 1.78 B | USA |
 |
ImmuCell Corporation
ICCC
|
47.5 | $ 8.44 | - | $ 76.2 M | USA |
 |
Immuron Limited
IMRN
|
148 | $ 0.83 | 3.44 % | $ 6.55 M |  Australia |
 |
Incyte Corporation
INCY
|
66.6 | $ 98.87 | -0.23 % | $ 19.3 B | USA |
 |
InMed Pharmaceuticals
INM
|
3.83 | $ 0.71 | 1.28 % | $ 1.74 M |  Canada |
 |
INmune Bio
INMB
|
19.9 K | $ 1.35 | 1.5 % | $ 33.4 M | USA |
 |
Innoviva
INVA
|
24.6 | $ 23.13 | 0.35 % | $ 1.56 B | USA |
 |
Aeterna Zentaris
AEZS
|
146 | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
186 | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
216 | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.114 | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | USA |
 |
Jaguar Health
JAGX
|
48.3 | $ 7.55 | -4.13 % | $ 17.6 M | USA |
 |
KalVista Pharmaceuticals
KALV
|
9.64 | $ 26.67 | -0.02 % | $ 1.44 B | Britain |
 |
Kamada Ltd.
KMDA
|
103 | $ 8.15 | 0.49 % | $ 260 M |  Israel |
 |
Kazia Therapeutics Limited
KZIA
|
28.7 | $ 13.24 | 6.56 % | $ 1.75 B | Australia |
 |
Ligand Pharmaceuticals Incorporated
LGND
|
77.8 | $ 223.98 | -0.39 % | $ 4.1 B | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
28.1 | $ 3.22 | 7.69 % | $ 5.3 M | Israel |
 |
Liquidia Corporation
LQDA
|
65.5 | $ 38.39 | 0.62 % | $ 3.3 B | USA |
 |
CureVac N.V.
CVAC
|
13.6 | - | - | $ 867 M |  Germany |
 |
Aquestive Therapeutics
AQST
|
103 | $ 4.08 | 0.74 % | $ 436 M | USA |